Stefan Geschwindner

R&d, 
Goeteborg, O, SE 
R&d, 
Goeteborg, O, SE 

Overview

Stefan Geschwindner practices practicing medicine in Goeteborg, Sweden.

His clinical expertise encompasses Heterozygous Familial Hypercholesterolemia (HeFH) and High Cholesterol.

He is actively involved in clinical research, co-authoring 43 peer reviewed articles.

Gender

Male

Locations

R&d, Goeteborg, O, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

43 Total Publications

Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive Patients.
Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive Patients.
Journal: Circulation
Published: May 15, 2026

Frequently Asked Questions about Stefan Geschwindner

Is Stefan Geschwindner a top-rated expert for Heterozygous Familial Hypercholesterolemia (HeFH)?

MediFind is an objective health platform that identifies experts based on real-world data. Stefan Geschwindner is classified as an Experienced expert for Heterozygous Familial Hypercholesterolemia (HeFH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Stefan Geschwindner participate in research or clinical trials?

Yes. Stefan Geschwindner has published 43 articles and abstracts on conditions like Heterozygous Familial Hypercholesterolemia (HeFH). You can view a list of Stefan Geschwindner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Geschwindner's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile